Catherine S. Gibson

Catherine S. Gibson

Auto-generated profile, based on publicly available information

Catherine S. Gibson

Department of Obstetrics and Gynaecology, The University of Adelaide, Adelaide, South Australia

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2006 in BMJ
Verified
Journal Article
Closed access
PDF file
CGCatherine S Gibson
Catherine S Gibson
AMAlastair H MacLennan
Alastair H MacLennan
PGPaul N Goldwater
Paul N Goldwater
EHEric A Haan
Eric A Haan
KPKevin Priest
Kevin Priest
GDGustaaf A Dekker
Gustaaf A Dekker
Objective To investigate the association between cerebral palsy and direct evidence for perinatal exposure to neurotropic viruses. Design Population based case-control study. Setting Adelaide Women's and Children's Hospital Research Laboratory. Participants and main outcome measures Newborn screening cards of 443 white case patients with cerebral palsy and 883 white controls were tested for viral nucleic acids from enteroviruses and herpes viruses by using polymerase chain reaction. Herpes group A viruses included herpes simplex viruses 1 and 2 (HSV-1 and HSV-2), Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human herpes virus 8 (HHV-8), and herpes group B viruses included varicella zoster virus (VZV) and human herpes viruses 6 and 7 (HHV-6 and HHV-7). Results The prevalence of viral nucleic acids in the control population was high: 39.8% of controls tested positive, and the prevalence was highest in preterm babies. The detection of herpes group B viral nucleic acids increased the risk of developing cerebral palsy (odds ratio 1.68, 95% confidence interval 1.09 to 2.59). Conclusions Perinatal exposure to neurotropic viruses is associated with preterm delivery and cerebral palsy.

1 March 2006 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
CGCatherine S. Gibson
Catherine S. Gibson
AMAlastair H. MacLennan
Alastair H. MacLennan
PGPaul N. Goldwater
Paul N. Goldwater
EHEric A. Haan
Eric A. Haan
KPKevin Priest
Kevin Priest
GDGustaaf A. Dekker
Gustaaf A. Dekker

1 April 2006 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
CGCatherine S. Gibson
Catherine S. Gibson
AMAlastair H. MacLennan
Alastair H. MacLennan
NJNard G. Janssen
Nard G. Janssen
WKWillem J. Kist
Willem J. Kist
WHWilliam M. Hague
William M. Hague
GDGustaaf A. Dekker
Gustaaf A. Dekker

1 May 2008 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
CGCatherine S. Gibson
Catherine S. Gibson
AMAlastair H. MacLennan
Alastair H. MacLennan
PGPaul N. Goldwater
Paul N. Goldwater
EHEric A. Haan
Eric A. Haan
KPKevin Priest
Kevin Priest
GDGustaaf A. Dekker
Gustaaf A. Dekker

21 December 2010 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
PDF file
CGCatherine S. Gibson
Catherine S. Gibson
AMAlastair H. Maclennan
Alastair H. Maclennan
EHEric A. Haan
Eric A. Haan
KPKevin Priest
Kevin Priest
GDGustaaf A. Dekker
Gustaaf A. Dekker
Objective. To investigate the roles of inherited polymorphisms in the MBL2 gene and exposure to viral infection in the development of a range of adverse pregnancy outcomes, including birthweight <10th percentile (small-for-gestational age, SGA), antepartum hemorrhage (APH), pregnancy-induced hypertensive disorders (PIHD), and preterm birth (PTB). Methods. This was a case–control study using DNA from newborn screening cards of 717 cases (babies with at least one of the adverse pregnancy outcomes listed above) and 609 controls, to screen for six polymorphisms within the MBL2 gene. These combine to create haplotypes with high (HYPA), intermediate (LYQA, LYPA), low (LXPA), and defective (HYPD, LYQC, LYPB) circulating MBL2 levels. Results. Significant associations were found between variant MBL2 haplotypes and SGA (LYPA <32 weeks OR 5.37, 95% CI 1.50–17.27), antepartum hemorrhage (LYPA <37 weeks OR 2.29, 95% CI 1.25–4.18), and PIHD (LYQC <32 weeks (OR 17.89, 95% CI 2.20–139.57). Evidence of exposure to infection increased the effect of these associations, (SGA OR 17.00, 95% CI 1.03–252.48; APH OR 5.67, 95% CI 1.73–18.84; PIHD OR 23.80, 95% CI 1.08–1414.76), while no evidence of exposure to infection demonstrated no associations. PTB was significantly associated with the defective HYPD haplotype with evidence of exposure to infection (OR 6.14, 95% CI 1.21–29.89). Conclusions. This research suggests that the combination of fetal MBL2 haplotypes and exposure to in utero viral infection increases the risk of adverse pregnancy outcomes, including PTB, antepartum hemorrhage, small-for-gestational age and PIHD.

1 March 2009 in Obstetrical & Gynecological Survey
Verified
Journal Article
Closed access
CGCatherine S. Gibson
Catherine S. Gibson
AMAlastair H. MacLennan
Alastair H. MacLennan
GDGustaaf A. Dekker
Gustaaf A. Dekker
PGPaul N. Goldwater
Paul N. Goldwater
TSThomas Sullivan
Thomas Sullivan
KNKarin B. Nelson
Karin B. Nelson
Interference with delivery of oxygen to the fetus or infant and other environmental risk factors have been associated with the development of cerebral palsy (CP). Several lines of evidence suggest that genetic risk factors are also involved; genes associated with vascular disease or inflammation, the fetal inflammatory response, and the apolipoprotein E genotype are all associated with increased susceptibility to CP. In addition, increased risk of CP has been demonstrated among groups with high rates of consanguinity and in certain families. This population-based study evaluated the association of selected genetic polymorphisms with later-diagnosed CP among 413 South Australian children born to Caucasian mothers between 1986 and 1999. Blood samples obtained from newborn screening blood spots were tested for 28 single-nucleotide polymorphisms (SNPs) using TaqMan assays. The genotype frequencies were evaluated in all cases of cerebral palsy, and in subgroups based on gestational age (<37 or ≥37 weeks), the type of cerebral palsy (diplegia, hemiplegia, or quadriplegia), and gender. Logistic regression models were used to assess associations between genotypic distributions and CP. The risk for CP in both gestational age groups was significantly associated with polymorphisms of 2 SNPs: inducible nitric oxide synthase (iNOS) and lymphotoxin α (also called LTA or tumor necrosis factor β (TNF-β). For iNOS, presence of the T allele was more common in all children with CP and among heterozygotes born at term. Homozygous variant status for LTA was associated with risk for CP and with spastic hemiplegic or quadriplegic CP. In addition to iNOS, heterozygosity for the endothelial protein C receptor SNP was more frequent among children with CP. Among infants born preterm, the variant A allele of interleukin 8 and heterozygosity for the β-2 adrenergic receptor were associated with CP. Interleukin 8 heterozygosity was associated with spastic diplegia. Some gene variants were found in girls with CP but not in boys. These findings, together with previous studies, suggest that certain genes are associated with increased susceptibility to CP.